Skin topical composition

A stabilized skin composition with specific ingredients ensures long-term stability and enhanced richness and penetration of liposomes and emulsions, addressing stability issues and improving skin care efficacy.

JP7587563B2Active Publication Date: 2024-11-20KOSE CORPORATION
View PDF 14 Cites 0 Cited by

Patent Information

Application Number
JP2022188928
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-12-27
Filing Date
2022-11-28
Publication Date
2024-11-20
Estimated Expiration
2042-11-28

AI Technical Summary

Technical Problem

Existing skin care compositions containing both liposomes and emulsions face stability issues due to particle changes such as collision, aggregation, and coalescence, leading to unsatisfactory richness and penetration sensation.

Method used

A skin composition comprising specific ratios of phospholipids, phytosterols, polyhydric alcohols, dimethicone, and higher alcohols, with a minimum 10% content of the oil agent and 1-5% paste-like polar oil at 25°C, stabilizes liposomes and emulsions, enhancing their coexistence and providing a rich, penetrating feel.

Benefits of technology

The composition achieves excellent stability, richness, and penetration sensation by maintaining the integrity of liposomes and emulsions, offering a high emollient effect and improved skin care benefits.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007587563000001
    Figure 0007587563000001
Patent Text Reader

Abstract

To provide an external composition for skin in which liposome and emulsion stably coexist, and furthermore, which has excellent moist / rich feeling and penetrating feeling.SOLUTION: An external composition for skin contains (A) phospholipid, (B) phytosterol, (C) liposome containing polyhydric alcohol having an IOB value of 1.8 to 3.5 and polyhydric alcohol having an IOB value of 4.5 to 5.5, (D) phospholipid, (E) an oil agent containing dimethicone and polar oil which is pasty at 25°C, and (F) emulsion containing higher alcohol, where the content of the component (E) with respect to the entire external composition for skin is 10 mass% or more, and contains the oil agent which is pasty at 25°C by 1 to 5 mass% with respect to the entire external composition for skin.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a composition for external use on the skin. [Background technology]

[0002] Liposomes, which are closed vesicles of phospholipids, are widely used in the pharmaceutical and cosmetic fields as skin care base materials for the purpose of delivering active ingredients and retaining them in the stratum corneum (see, for example, Patent Documents 1 and 2). In recent years, in the cosmetic field, there has been a demand for higher skin care effects and a wide range of texture options, and attempts have been made to incorporate liposomes and emulsions at high concentrations (see, for example, Patent Document 3). However, when liposomes and emulsions coexist, the particle forms of the liposomes and emulsions may change due to collision, aggregation, coalescence, etc., of the two particles, and there have been problems in stably coexisting the two particles for a long period of time. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] Japanese Patent Application Publication No. 8-183726 [Patent Document 2] JP 2008-266324 A [Patent Document 3] International Publication No. 2000 / 000178 Brochure Summary of the Invention [Problem to be solved by the invention]

[0004] Although products in which liposomes and emulsions coexist have been known, and although they provide a high level of penetration as a liposome-containing composition, they have not provided a satisfactory richness as a cream. In this specification, the term "richness" refers to a moist and rich feel when used, or an oily feel when used. Therefore, an object of the present invention is to provide a composition for external use on the skin in which both the liposome and emulsion particles are stable for a long period of time, and which has an excellent penetration feeling due to the liposome particles and a rich feeling due to the emulsion particles. [Means for solving the problem]

[0005] As a result of extensive research, the present inventors have investigated the respective compositions of liposomes and emulsions, and have completed the present invention.

[0006] That is, the present invention provides: Component (A) Phospholipids Ingredient (B) Phytosterol Component (C) a liposome containing a polyhydric alcohol having an IOB value of 1.8 to 3.5 and a polyhydric alcohol having an IOB value of 4.5 to 5.5; Component (D) Phospholipids Ingredient (E) An oil agent containing dimethicone and a polar oil that is paste-like at 25°C. An emulsion containing component (F) a higher alcohol; Contains The present invention relates to a composition for topical skin application, in which the content of the component (E) in the entire composition for topical skin application is 10% by mass or more, and which contains a paste-like polar oil at 25°C in an amount of 1 to 5% by mass relative to the entire composition for topical skin application. Effect of the Invention

[0007] The composition for external use on the skin of the present invention has excellent coexistence stability between liposomes and emulsions, and is also excellent in terms of penetration and richness when applied to the skin. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0008] Hereinafter, the embodiments of the present invention will be described. However, the present invention is not limited to only the following embodiments. In this specification, "X to Y" indicating a range includes X and Y and means "X or more and Y or less". In addition, the upper limit value (or less) and the lower limit value (or more) of each numerical range (~) can be arbitrarily combined as desired. In addition, in the content and the like in this specification, "in the composition for external use on skin" means "in the total mass of the composition for external use on skin". In this specification, percentages are expressed by mass (mass / mass%) unless otherwise specified.

[0009] The present invention can provide a composition for external use on the skin, which contains (i) a liposome containing component (A) a phospholipid, component (B) a phytosterol, and component (C) a polyhydric alcohol having an IOB value of 1.8 to 3.5 and a polyhydric alcohol having an IOB value of 4.5 to 5.5, and (ii) an emulsion containing component (D) a phospholipid, component (E) an oil agent containing dimethicone and a polar oil that is pasty at 25°C, and component (F) a higher alcohol. It is preferable that the composition for external use on the skin contains or uses components (A) to (F). It is preferable that the content of component (E) in the external use on the skin is 10% by mass or more of the total mass of the composition for external use on the skin, and the content of the polar oil that is pasty at 25°C is 1 to 5% by mass of the total mass of the composition for external use on the skin.

[0010] <Liposome> The liposome in the present invention refers to a spherical closed endoplasmic reticulum formed by a phospholipid bilayer membrane, and can be obtained as a liposome dispersion by dispersing the components (A) to (C) in an aqueous solvent.

[0011] (Component (A) Phospholipids) The phospholipid component (A) used in the liposome of the present invention is a lipid having a phosphate ester moiety in its molecular structure, and is not particularly limited as long as it forms a bilayer membrane, and examples thereof include phosphatidylcholine, phosphatidylethanolamine, sphingomyelin, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol, and phosphatidic acid. Among these, from the viewpoint of the stability of liposome particles, phosphatidylcholine and phosphatidylethanolamine are preferred, and phosphatidylcholine (PC) is more preferred. Specifically, a mixture of the above phospholipids having different compositions depending on their origin (e.g., soybean-derived, egg yolk-derived) can be used, and is not particularly limited as long as it is used in ordinary cosmetics, quasi-drugs, pharmaceuticals, etc., and examples thereof include soybean-derived phospholipids, soybean-derived hydrogenated phospholipids, soybean-derived lysophospholipids, soybean-derived hydrogenated lysophospholipids, egg yolk-derived phospholipids, egg yolk-derived hydrogenated phospholipids, egg yolk-derived lysophospholipids, and egg yolk-derived hydrogenated lysophospholipids. These phospholipids can be used by selecting one or more kinds as necessary. From the viewpoint of stability, more preferred are soybean-derived hydrogenated phospholipids and soybean-derived hydrogenated lysophospholipids, and more preferred are soybean-derived hydrogenated phospholipids and / or soybean-derived hydrogenated lysophospholipids. Among these phospholipids, from the viewpoint of liposome particle stability, those with high phosphatidylcholine (PC) purity (preferably 70% by mass or more of PC in the phospholipid) can be preferably used. Specifically, commercially available products such as NIKKOL Resinol S-10E (manufactured by Nikko Chemicals Co., Ltd.; soybean-derived), Basis LS-60HR (manufactured by Nisshin Oillio Group Co., Ltd.; soybean-derived), egg yolk lecithin PL-100P (manufactured by Kewpie Corporation; egg yolk-derived), and HSL-70 (manufactured by YMC Co., Ltd.; soybean-derived) can be used.

[0012] Component (A) is contained in the composition for external use on skin as a main component forming the lipid bilayer membrane of the liposome particles, and due to the moisturizing effect and skin affinity of the phospholipid itself, it can impart a higher penetration feeling and moisturizing effect to the composition for external use on skin of the present invention.

[0013] The content of component (A) in the present invention is not particularly limited, but from the viewpoint of the coexistence stability of liposome and emulsion, it is preferably 0.5% by mass (hereinafter simply referred to as "%) or more in the composition for external use on skin, more preferably 1% or more, and even more preferably 1.5% or more. Also, from the viewpoint of the coexistence stability of liposome and emulsion, it is preferably 10% or less in the composition for external use on skin, more preferably 7% or less, and even more preferably 5% or less.

[0014] (Component (B) Phytosterol) The component (B) phytosterol used in the liposome of the present invention is a type of sterol, but is a component contained in small amounts in plants such as soybeans and rapeseeds. It is not particularly limited as long as it is used in ordinary cosmetics, quasi-drugs, medicines, etc., and a commercially available product may be used. The component (B) phytosterol used in the present invention is a mixture of sterols containing multiple types of phytosterols such as β-sitosterol, campesterol, stigmasterol, brassicasterol, etc. Component (B) contributes to the stability of the lipid bilayer structure, and can improve the stability of the liposome by combining with component (A). An example of a commercially available product is Phytosterol QI (manufactured by Mitsubishi Chemical Foods Corporation).

[0015] The content of component (B) in the present invention is not particularly limited, but from the viewpoint of the coexistence stability of liposome and emulsion, it is preferably 0.1% or more in the composition for external use on skin, more preferably 0.3% or more, and more preferably 1% or less in the composition for external use on skin, more preferably 0.8% or less, and even more preferably 0.5% or less.

[0016] (Component (C) Polyhydric alcohols with an IOB value of 1.8 to 3.5 and polyhydric alcohols with an IOB value of 4.5 to 5.5) The polyhydric alcohol of component (C) used in the liposome of the present invention has a structure having two or more hydroxyl groups in the molecule, and is not particularly limited as long as it is one that is normally used in cosmetics, quasi-drugs, pharmaceuticals, etc., but one having an IOB value in the range of 1.8 to 3.5 and one having an IOB value in the range of 4.5 to 5.5 are used in combination. Component (C) contributes to the solubility of components (A) and (B), and by combining one having a specific IOB value, the stability of the liposome can be improved.

[0017] The IOB value in the present invention is a value calculated based on the organic concept diagram (Fujita Atsushi, Prediction of Organic Compounds and Organic Concept Diagram, Chemistry Area VOL. 11, No. 10 (1957) 719-715). More specifically, in this organic concept diagram, the physicochemical properties of a compound are expressed by defining the degree of properties mainly due to Van Der Waals forces as "organic" and the degree of properties mainly due to electrical affinity as "inorganic". The IOB value is an index showing the balance between inorganic and organic properties, and is expressed as IOB value = inorganic value / organic value. It can be said that the compound with a larger IOB value is more hydrophilic and polar.

[0018] Specific examples of component (C) include polyhydric alcohols having an IOB value in the range of 1.8 to 3.5, such as dipropylene glycol (IOB value = 1.8), 1,3-butylene glycol (IOB value = 2.5), 1,3-propanediol (IOB value = 3.3), and diglycerin (IOB value = 3.5), and examples of polyhydric alcohols having an IOB value in the range of 4.5 to 5.5 include glycerin (IOB value = 5.0), sorbitol (IOB value = 5.0), and one or more of each can be selected and used as necessary. From the viewpoint of liposome stability, a combination of one or more selected from the group consisting of dipropylene glycol and 1,3-butylene glycol and glycerin is preferred, a combination of dipropylene glycol and / or 1,3-butylene glycol and glycerin is more preferred, and a combination of 1,3-butylene glycol and glycerin is even more preferred. From the viewpoint of liposome stability, it is more preferable to contain or use at least 1,3-butylene glycol and glycerin as component (C), and these can be further combined with other components, for example, a combination of dipropylene glycol and 1,3-butylene glycol with glycerin.

[0019] The content of component (C) in the present invention is not particularly limited, but from the viewpoint of the stability of the liposome, the total content of the polyhydric alcohol of component (C) in the composition for external use on the skin is preferably 1% or more, more preferably 3% or more, and more preferably 10% or less, more preferably 7% or less in the composition for external use on the skin.

[0020] In the present invention, the content of the component (C) is preferably 0.5 to 9.5% and more preferably 1 to 5% of the polyhydric alcohol having an IOB value in the range of 1.8 to 3.5 in the composition for external use on skin. Also, the content of the polyhydric alcohol having an IOB value in the range of 4.5 to 5.5 in the composition for external use on skin is preferably 0.5 to 9.5% and more preferably 1 to 5%. This range is preferable because it ensures the stability of the liposome itself. The content or usage mass ratio of polyhydric alcohol having an IOB value in the range of 1.8-3.5:polyhydric alcohol having an IOB value in the range of 4.5-5.5 is preferably 0.5-9.5:9.5-0.5, more preferably 1-5:5-1.

[0021] As described above, the liposomes of the present invention exist in a dispersed state in an aqueous solvent, and therefore contain, as the aqueous solvent, one or more aqueous components selected from water, lower alcohols (preferably having 1 to 4 carbon atoms, e.g., EtOH), etc. In addition to the essential components of components (A) to (C), one or more components selected from oils, surfactants, water-soluble polymers, various cosmetic active ingredients, fragrances, etc. may be appropriately contained within a range that does not impair the structure of the liposomes.

[0022] The method for producing liposomes is not particularly limited, and liposomes are prepared by a conventional method. For example, components (A) to (C) are heated and mixed uniformly in advance, and heated aqueous components are added thereto while stirring to obtain a liposome dispersion. The mixing temperature at this time is not particularly limited, but may be, for example, 60 to 80°C. The dispersion thus obtained is observed under a polarizing microscope under crossed Nicols, and a Maltese cross image is confirmed to confirm the formation of a lipid bilayer membrane.

[0023] The average particle size of the liposomes in the present invention is not particularly limited, but from the viewpoint of more suitably exerting the effects of the present invention, it is preferably 50 to 600 nm, more preferably 100 to 500 nm. The average particle size can be measured using a real-time nanoparticle size measuring device DelsaMax CORE (manufactured by Beckman Coulter, Inc.) (see (Method of measuring average particle size) in [Examples] below).

[0024] <Emulsion> The emulsion in the present invention refers to emulsified droplets in an oil-in-water emulsion composition obtained by emulsifying components (D) to (F) in an aqueous solvent.

[0025] (Component (D) Phospholipids) The phospholipid component (D) used in the emulsion of the present invention is the same as the phospholipid component (A) used in the liposome described above, and the description of the phospholipid component (A) can be appropriately adopted. The phospholipid component (D) is contained as an emulsifier in the oil-in-water emulsion composition, and an optimal one can be selected independently of the phospholipid component (A). However, from the viewpoint of stability as a skin topical composition, the phospholipid component (D) is preferably the same type as the phospholipid component (A). It is more preferable to use soybean-derived hydrogenated phospholipid and / or soybean-derived hydrogenated lysophospholipid as the phospholipid component (D). In addition, the moisturizing effect and skin affinity of the phospholipid itself can impart a higher penetration feeling and moisturizing effect to the skin topical composition of the present invention.

[0026] The content of component (D) in the present invention is not particularly limited, but from the viewpoint of the coexistence stability of the liposome and the emulsion, it is preferably 0.5% or more, more preferably 1% or more, and more preferably 5% or less, even more preferably 3% or less in the composition for external use on skin.

[0027] (Component (E) Oil containing dimethicone and a polar oil that is paste-like at 25°C) The oil of component (E) used in the emulsion of the present invention contains at least dimethicone and a polar oil that is pasty at 25° C. The oil of component (E) is not particularly limited as long as it is one that is normally used in cosmetics, quasi-drugs, medicines, etc., and does not matter whether it is solid, pasty, liquid, or has other physical properties such as polarity or non-polarity, but it essentially contains a polar oil that is pasty at 25° C. In addition, regardless of the origin of the oil, such as vegetable oil, mineral oil, or synthetic oil, examples of the oil include hydrocarbons, oils and fats, waxes, esters, fatty acids, silicone oils, and fluorine-based oils, but it essentially contains dimethicone. Specific examples of oils include hydrocarbon oils such as liquid paraffin, squalane, hydrogenated polyisobutene, hydrogenated polydecene, and petrolatum; ester oils such as triethylhexanoin, trimethylolpropane triisostearate, glycerin tri(capryl / capric) acid, di(octyldodecyl / phytosteryl / behenyl) lauroyl glutamate, phytosteryl macadamiate, phytosteryl oleate, and dipentaerythrityl hexa(hydroxystearic acid / stearic acid / rosin acid); vegetable oils such as meadowfoam oil, safflower oil, olive oil, castor oil, jojoba oil, and macadamia nut oil; silicone oils such as decamethylcyclopentasiloxane, dimethicone, methylphenylpolysiloxane, and (dimethicone / vinyl dimethicone) crosspolymer; and oil-soluble beauty ingredients, and these can be used singly or in combination as needed.

[0028] The dimethicone in the oil agent of component (E) is a linear silicone oil, also called dimethylpolysiloxane, in which all the side chains and ends of the polysiloxane are methyl groups. There are no particular limitations on the dimethicone, but from the viewpoint of the coexistence stability and permeability of the liposome and emulsion, it is preferable to use a dimethicone having a kinetic viscosity of 100 mm at 25°C. 2 In the present invention, the kinematic viscosity is a value measured at 25° C. by a measuring method according to ASTM D445.

[0029] The polar oil in the oil solution of component (E) that is pasty at 25°C refers to a polar oil that has a melting point at a temperature above 25°C and a viscosity at 30°C of 5000 to 100000 mPa·s. In the present invention, the viscosity refers to a value measured using a single cylinder rotational viscometer Vismetron Model VS-A1 (manufactured by Shibaura Systems Co., Ltd.) after leaving a sample at 30°C for one day. The melting point is not particularly limited, but is more preferably above 25°C and not higher than 60°C, and is particularly preferably 30 to 55°C. In addition, any oil having polarity such as ester oil can be used, and specific examples of the polar oil that is pasty at 25°C include N-acylamino acid esters, glycerin fatty acid esters, dimer acid esters, dipentaerythritol fatty acid esters, fatty acid cholesteryl esters, fatty acid phytosteryl esters, etc.More specifically, N-acyl amino acid esters such as dioctyldodecyl N-lauroyl-L-glutamate, di(cholesteryl / octyldodecyl) N-lauroyl-L-glutamate, di(cholesteryl / behenyl / octyldodecyl) N-lauroyl-L-glutamate, di(phytosteryl / behenyl / octyldodecyl) N-lauroyl-L-glutamate; hexaglycerin fatty acid esters, decaglycerin fatty acid esters, glyceryl oligoesters (adipic acid / 2-ethylhexanoic acid / stearic acid), hydrogenated castor oil stearate, tri(caprylic / capric / myristic / stearic acid)glyceride, bisdiglyceryl polyacyladipate-2, hydrogenated castor oil hydroxystearic acid, and the like; dimer acid esters such as dimer dilinoleate di(isostearyl / stearyl / behenyl), dimer dilinoleate di(isostearyl / phytosteryl), dimer dilinoleyl bisisostearyl dimer dilinoleate; dipentaerythritol fatty acid esters such as dipentaerythritol (12-hydroxystearic acid / stearic acid / rosin acid), dipentaerythritol hexa(hydroxystearic acid / stearic acid / rosin acid), dipentaerythritol (12-hydroxystearic acid / isostearic acid); fatty acid cholesteryl esters such as cholesteryl isostearate, cholesteryl hydroxystearate, cholesteryl ricinoleate; fatty acid phytosteryl esters such as phytosteryl macadamia nut oil fatty acid; and the like, and these can be used alone or in combination as necessary. These paste-like polar oils can provide a better emollient feel to the skin topical composition. Among these, from the viewpoint of richness and stability of the topical skin composition, phytosteryl oleate, phytosteryl macadamia nut oil fatty acid, di(phytosteryl / behenyl / octyldodecyl) N-lauroyl-L-glutamate, dipentaerythrityl hexa(hydroxystearate / stearic acid / rosin acid), and mixtures of two or more selected from these are preferred, and are also more desirable from the viewpoint of emollient effect.

[0030] The content of component (E) in the present invention, as the total content of oils in the topical skin composition, from the viewpoints of the coexistence stability of the liposome and the emulsion, the richness and the emollient effect, is 10% or more, and more preferably 12% or more, and is preferably 30% or less, and more preferably 25% or less.

[0031] In the present invention, the content of the component (E) is, from the viewpoint of producing a sufficient richness at 25° C., 1-5% of the paste-like polar oil in the composition for external use on the skin, more preferably 2-4%. The content of dimethicone in the composition for external use on the skin is preferably 0.1-5%, more preferably 0.5-3%. The content of the paste-like polar oil and dimethicone in the total content of the oil agent at 25° C. is preferably 5-100%, more preferably 10-60%.

[0032] In the emulsion of the present invention, the oil of component (E) contains a non-polar oil containing dimethicone and a polar oil containing a polar oil that is pasty at 25°C, and the content mass ratio of the polar oil to the non-polar oil in component (E) is preferably 0.8 to 2, more preferably 1 to 1.8, (non-polar oil content mass) / (polar oil content mass). This content mass ratio may be a usage mass ratio. If the ratio is within this range, it is preferable because the coexistence stability of the liposome and the emulsion and the penetration feeling of the skin topical composition are further improved.

[0033] (Component (F) Higher alcohol) The higher alcohol component (F) used in the emulsion of the present invention is preferably a monohydric alcohol having a linear or branched hydrocarbon group having 12 to 22 carbon atoms. Any alcohol that is normally used in cosmetics, quasi-drugs, medicines, etc. can be used without any particular limitation, and specific examples include behenyl alcohol, stearyl alcohol, myristyl alcohol, cetyl alcohol, cetostearyl alcohol, lanolin alcohol, hydrogenated lanolin alcohol, lauryl alcohol, areyl alcohol, 2-octyldodecanol, hexadecyl alcohol, isostearyl alcohol, jojoba alcohol, etc., and one or more of these can be used. Among these, from the viewpoints of the coexistence stability of the liposome and the emulsion, the feeling of penetration, and the richness, it is preferable to use one or more selected from the group consisting of cetostearyl alcohol and behenyl alcohol, and cetostearyl alcohol and / or behenyl alcohol are preferable, and the mixing ratio of these is, for example, 1 to 2:2 to 1.

[0034] The content of component (F) in the present invention is not particularly limited, but from the viewpoints of the coexistence stability of the liposome and emulsion, the feeling of penetration, and the richness, it is preferably 0.2% or more in the topical skin composition, more preferably 0.5% or more, and even more preferably 0.8% or more, and is preferably 5% or less, and even more preferably 3% or less.

[0035] Since the emulsion of the present invention exists in the form of an oil-in-water emulsion composition as described above, the components constituting the aqueous phase may appropriately contain water and aqueous components such as polyhydric alcohols and lower alcohols, or components used in ordinary oil-in-water emulsion cosmetics, within the scope of not impairing the effects of the present invention. For example, the emulsion may contain oils other than component (E), surfactants (auxiliaries) other than components (D) and (F), water-soluble polymers, ultraviolet absorbers, antioxidants, antibacterial agents, preservatives, moisturizers, pH adjusters, cooling agents, powders, vitamins, cosmetic ingredients, fragrances, etc.

[0036] The method for producing the emulsion is not particularly limited, and the emulsion can be prepared by a conventional method. For example, the components (D) to (F) and, if necessary, other components are dissolved by heating (for example, at about 60 to 80° C.) and added to an aqueous component, and the mixture is stirred to emulsify the mixture to prepare an oil-in-water emulsion composition.

[0037] The average particle size of the emulsion in the present invention is not particularly limited, but from the viewpoint of more suitably exerting the effects of the present invention, it is preferably 0.8 to 10 μm, more preferably 1 to 7 μm. The average particle size of the emulsion can be measured visually using a transmission microscope (see (Method of measuring average particle size) in [Examples] below).

[0038] <Skin external composition> As described above, the present invention can provide a composition for external use on the skin, which comprises (i) a liposome containing the components (A) to (C), and (ii) an emulsion containing the components (D) to (F). Furthermore, it is preferable that the composition for external use on the skin contains 10% by mass or more of the component (E) based on the total mass of the composition, and that the composition for external use on the skin contains 1 to 5% by mass of a polar oil in a paste form at 25°C based on the total mass of the composition. The total content of component (A) and component (D) in the composition for external use on skin is as described above. The total amount of these two components is not particularly limited, but a suitable lower limit is preferably 1% or more, more preferably 2% or more, and even more preferably 2.5% or more, and a suitable upper limit is preferably 15% or less, more preferably 10% or less, and even more preferably 8% or less.

[0039] The skin topical composition of the present invention has excellent coexistence stability of liposomes and emulsion, and has excellent penetration and richness when applied to the skin. Furthermore, the skin topical composition of the present invention can be useful as a skin care cosmetic with high emollient effect. It is more preferable that the skin topical composition of the present invention is a composition with high emollient feeling, and this can be made into a composition with high emollient feeling by including the component (E), more specifically, by including dimethicone and a polar oil that is paste-like at 25°C. In addition, polar oil is also preferable from the viewpoint of richness. In addition, when evaluating the emollient feeling, it can be evaluated using the evaluation method of "2. Richness" and "Penetration"" in the Examples described later.

[0040] The change rate in the composition for external use on the skin of the present invention is preferably less than 60%, more preferably less than 50%, even more preferably less than 40%, more preferably less than 30%, and more preferably less than 20%. It is considered that the lower the change rate, the higher the coexistence stability of the liposome and emulsion.

[0041] The skin external composition of the present invention can be obtained by mixing a solution containing liposomes containing components (A) to (C) with a solution containing an emulsion containing components (D) to (F). It can also be obtained by adding a dispersion containing liposomes containing components (A) to (C) to a solution containing an emulsion containing components (D) to (F) and mixing them. The temperature during mixing is preferably about 20 to 50°C. At this time, the content mass ratio or usage mass ratio of components (A): (B): (C) is not particularly limited, but is preferably 0.5 to 10: 0.1 to 1: 1 to 10, more preferably 1 to 7: 0.3 to 0.8: 3 to 7, and even more preferably 1.5 to 5: 0.3 to 0.5: 3 to 7. The content mass ratio or usage mass ratio of component (D):component (E):component (F) is not particularly limited, but is preferably 0.5-5:10-30:0.2-5, more preferably 1-3:12-25:0.5-3, and even more preferably 1-3:12-25:0.8-3. The content mass ratio or usage mass ratio may be determined by appropriately combining the contents of the above-mentioned respective components (components (A) to (F)).

[0042] In addition to the liposomes (dispersions) and emulsions (oil-in-water emulsion compositions), the skin topical composition of the present invention may appropriately contain ingredients that are typically incorporated into cosmetics and skin topical compositions for the purpose of adjusting texture such as richness and penetration, improving the coexistence stability of liposomes and emulsions, etc., within a range that does not impair the effects of the present invention. Specific examples of such ingredients include lower alcohols, aqueous ingredients such as moisturizers, water-soluble polymers, powders, film-forming agents, surfactants other than essential ingredients, oil-soluble gelling agents, organically modified clay minerals, resins, ultraviolet absorbers, preservatives, antibacterial agents, fragrances, antioxidants, pH adjusters, chelating agents, skin active ingredients, etc.

[0043] Examples of aqueous components include sugar alcohols such as sorbitol, maltitol, and glucose; lower alcohols such as ethanol; glycerin derivatives such as polyglycerin-3, polyoxybutylene polyoxyethylene polyoxypropylene glyceryl ether (3BO) (8EO) (5PO), and polyoxypropylene (9) diglyceryl; and polyhydric alcohols.

[0044] Examples of the water-soluble polymer include xanthan gum, methylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, carboxyvinyl polymer, alkyl-modified carboxyvinyl polymer, mucopolysaccharides, etc., and one or more of these can be used. Among these, from the viewpoint of stability and usability as a skin topical composition, carboxyvinyl polymer, alkyl-modified carboxyvinyl polymer, and xanthan gum are more preferred.

[0045] From the viewpoint of stability of the composition for external use on skin of the present invention, the pH is preferably 4 to 7. In the present invention, the pH was measured at 20° C. using a glass electrode type hydrogen ion concentration meter (manufactured by Horiba, Ltd.).

[0046] The skin topical composition of the present invention can be used as a medicinal skin topical agent, a quasi-drug, or a cosmetic, and examples of such products include lotions, milky lotions, creams, beauty essences, massage products, pack products, hand creams, body lotions, sunscreens, scalp treatments, medicinal lotions, etc. Milky lotions and creams are preferred in that they provide a rich feeling, and preferred methods of use include using the skin on the hands, fingers, or cotton.

[0047] The present technology may employ the following configurations or technical features as appropriate. 〔1〕 Component (A) Phospholipids Ingredient (B) Phytosterol Component (C) Polyhydric alcohols having an IOB value of 1.8 to 3.5 and polyhydric alcohols having an IOB value of 4.5 to 5.5 A liposome containing Component (D) Phospholipids Ingredient (E) An oil agent containing dimethicone and a polar oil that is paste-like at 25°C. Ingredient (F) Higher alcohol and an emulsion comprising: Contains A skin topical composition, the content of the component (E) being 10% by mass or more relative to the entire skin topical composition, and containing a paste-like polar oil at 25°C in an amount of 1 to 5% by mass relative to the entire skin topical composition. 〔2〕 The composition for external use on the skin according to the above item [1], wherein the mass ratio of the non-polar oil containing dimethicone to the polar oil containing a polar oil that is pasty at 25°C in the component (E): (mass of non-polar oil) / (mass of polar oil) is 0.8 to 2.

[0048] 〔3〕 The composition for external use on the skin according to [1] or [2] above, wherein the content of the component (A) in the composition for external use on the skin is 0.5 to 10% by mass. 〔4〕 The composition for external use on the skin according to any one of [1] to [3] above, wherein the content of the component (B) in the composition for external use on the skin is 0.1 to 1 mass %. 〔5〕 The composition for external use on the skin according to any one of [1] to [4] above, wherein the content of the component (C) in the composition for external use on the skin is 1 to 10 mass %. 〔6〕 The composition for external use on the skin described in any one of [1] to [5] above, wherein the content mass ratio or usage mass ratio of the polyhydric alcohol having an IOB value of 1.8 to 3.5: the polyhydric alcohol having an IOB value of 4.5 to 5.5 in the component (C) is 0.5 to 9.5:9.5 to 0.5. 〔7〕 The composition for external application of skin according to any one of [1] to [6] above, wherein the content of the polyhydric alcohol having an IOB value of 1.8 to 3.5 in the component (C) is 0.5 to 9.5 mass% in the composition for external application of skin, and / or the content of the polyhydric alcohol having an IOB value of 4.5 to 5.5 is 0.5 to 9.5 mass% in the composition for external application of skin. 〔8〕 The composition for external use on the skin according to any one of the above [1] to [7], wherein the component (C) contains at least 1,3-butylene glycol and glycerin.

[0049] 〔9〕 The composition for external use on the skin according to any one of [1] to [8] above, wherein the content of the component (D) in the composition for external use on the skin is 0.5 to 5% by mass. 〔10〕 The composition for external use on the skin according to any one of [1] to [9] above, wherein the content of the component (E) in the composition for external use on the skin is 10 to 30% by mass. 〔11〕 The composition for external use on the skin according to any one of [1] to

[10] above, wherein the content of the component (E) a polar oil in a paste form at 25°C in the composition for external use on the skin is 1 to 5 mass% and / or the content of the component (E) dimethicone in the composition for external use on the skin is 0.1 to 5 mass%. 〔12〕 The composition for external use on the skin according to any one of [1] to

[11] above, wherein the component (E) polar oil which is a paste at 25°C is one or more selected from phytosteryl oleate, phytosteryl macadamia nut oil fatty acid, di(phytosteryl / behenyl / octyldodecyl) N-lauroyl-L-glutamate, and dipentaerythrityl hexa(hydroxystearate / stearic acid / rosin acid). 〔13〕 The composition for external use on the skin according to any one of the above [1] to

[12] , wherein the mass ratio of the non-polar oil containing dimethicone to the polar oil containing a polar oil in a paste form at 25°C in the component (E): (mass of non-polar oil content) / (mass of polar oil content) is 1 to 1.8. 〔14〕 The composition for external use on the skin according to any one of [1] to

[13] above, wherein the content of the component (F) in the composition for external use on the skin is 0.2 to 5% by mass. 〔15〕 The composition for external use on the skin according to any one of the above [1] to

[14] , wherein the component (F) is cetostearyl alcohol and / or behenyl alcohol.

[0050] 〔16〕 The composition for external use on skin described in any one of [1] to

[15] above, wherein the average particle size of the liposomes is 50 to 600 nm, and / or the average particle size of the emulsion is 0.8 to 10 μm. 〔17〕 The composition for external use on the skin described in any one of [1] to

[16] above, wherein the rate of change in the composition for external use on the skin is less than 40%. Rate of change = average particle size derived from liposomes of a sample stored at 40℃ for one month / average particle size derived from liposomes of a sample immediately after production EXAMPLES

[0051] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to the following examples in any way.

[0052] Examples 1 to 21 and Comparative Examples 1 to 4: Cream Creams of the examples and comparative examples were prepared according to the composition in Table 1 and the manufacturing method shown below. The obtained creams were evaluated and judged for "coexistence stability (of liposomes and emulsion)", "richness", and "penetration" according to the following evaluation method and criteria. The results are shown in Table 1. The phospholipids (No. 1 and No. 7: *1) of components (A) and (D) in Table 1 are hydrogenated phospholipids derived from soybeans (*1: NIKKOL Resinol S-10E (manufactured by Nikko Chemicals Co., Ltd.); hydrogenated soybean phospholipid, PC content 75 to 85%), with PC of 70% or more. The phytosterol (No. 2: *2) of component (B) in Table 1 is phytosterol (*2: Phytosterol QI (manufactured by Mitsubishi Chemical Foods Co., Ltd.)). The polar oils (No. 15 and 16) in component (E) in Table 1 that are paste-like at 25°C have a melting point of 30 to 55°C. The pH of the external skin compositions of Examples 1 to 21 is 4 to 7. The phospholipids and phytosterols used in Examples 22 and onwards are the same as those in *1 and *2.

[0053] [Table 1]

[0054] <Manufacturing method> A: Heat ingredients (1) to (5) to 70°C and mix uniformly. B: Heat component (6) to 70°C. C: Gradually add B to A and disperse using a Despa mixer. D: C was cooled to room temperature to prepare a liposome dispersion. E: Heat ingredients (7) to (9) to 70°C and mix uniformly. F: Components (10) to (19) are heated to 70°C and mixed uniformly. G: Heat ingredients (20) to (22) to 70°C and mix uniformly. H: Gradually add F to E and disperse using a Despa mixer. I: Gradually add G to H and emulsify using a Despa mixer. J: I was cooled to 40° C., and components (23) to (26) were gradually added and dispersed using a Despa mixer to prepare an emulsion composition. K: D was gradually added to J and mixed in a Despa mixer to obtain a cream containing both liposomes and emulsion.

[0055] <Evaluation method> 1. "Coexistence stability" of liposomes and emulsions When the particle size of the creams of the Examples and Comparative Examples is measured by the method described below, the particle size of the liposomes and the particle size of the emulsion are detected as respective peaks. Poor coexistence stability of the liposomes and the emulsion means that the particle size of the liposomes changes due to the collapse of the liposomes or the merging of the liposomes and the emulsion. Therefore, the peak value of the particle size derived from the liposomes immediately after production was used as a reference, and the same peak value after storage at a constant temperature of 40°C for one month was measured, and the "change rate" was calculated to evaluate the coexistence stability of the liposomes and the emulsion. (Method of measuring average particle size) After storing the compositions for one month at room temperature and at a constant temperature of 40°C, each sample was diluted 500-fold and filled into a plastic cuvette UVette 220-1600 nm (Eppendorf), and the peak particle size of each liposome and emulsion was measured using a real-time nanoparticle size measurement device DelsaMax CORE (Beckman Coulter, Inc.). The same sample was measured three times, and the average value of the three measurements was taken as the "average particle size." The "rate of change" was calculated using the following formula. Rate of change = average particle size derived from liposomes of a sample stored at 40℃ for one month / average particle size derived from liposomes of a sample immediately after production (Judgment criteria) ◎: The rate of change in average particle size is less than 20% ○: The rate of change in average particle size is 20% or more and less than ±40% △: The rate of change in average particle size is 40% or more and less than ±60% ×: The rate of change in average particle size is 60% or more.

[0056] 2. "Richness" and "penetration" Ten cosmetic evaluation experts, aged 35 to 50, applied a rice-sized amount of the cream from each of the Examples and Comparative Examples to the entire face twice a day, in the morning and evening, after washing their faces. The richness and penetration of each sample during use were evaluated on a 5-point scale using the following evaluation criteria, and the average score of each sample was also evaluated using the following criteria. (Evaluation Criteria) [Evaluation result]:[Score] Very good: 5 points Good: 4 points Average (neither positive nor negative): 3 points Slightly poor: 2 points Defective: 1 point (Judgment criteria) [Judgment]: [Average score] ◎: 4.5 or higher ○: 3.5 or more and less than 4.5 △: 1.5 or more and less than 3.5 ×: Less than 1.5

[0057] <Result> As is clear from Table 1 above, it was found that all of the creams of Examples 1 to 21 had excellent coexistence stability of the liposome and emulsion, had a sufficient richness, and also had an excellent penetration feeling. On the other hand, in Comparative Example 1, in which no phospholipid was used as an emulsifier for the emulsion, satisfactory results were not obtained in terms of the coexistence stability of the liposome and emulsion and the sense of penetration. In Comparative Example 2, in which the amount of oil was 10% or less, and Comparative Example 3, in which the amount of paste-like polar oil at 25°C was less than 1%, the sense of richness was insufficient. Furthermore, in Comparative Example 4, which did not contain a higher alcohol, satisfactory results were not obtained in terms of the coexistence stability of the liposome and emulsion and the sense of richness.

[0058] Example 22: Eye Cream (Component) (%) (1) Phospholipids 3 (2) Phytosterol 0.5 (3) Glycerin 5 (4) 1,3-butylene glycol 5 (5) Purified water 20 (6) Phospholipids 2.5 (7) Glycerin 10 (8) 1,3-butylene glycol 5 (9) Squalane 3 (10) Dimethicone (6CS) 3 (11) Hydrogenated polyisobutene 1 (12) Diphenylsiloxyphenyl trimethicone 1 (13) Jojoba oil 4 (14) Di(octyldodecyl / phytosteryl / behenyl) lauroyl glutamate 1 (15) Hexa(hydroxystearic acid / stearic acid / rosin acid) Dipentaerythrityl 1 (16) Hydrogenated castor oil stearate 1 (17) Cetostearyl alcohol 2 (18) Behenyl alcohol 1.5 (19) Remaining purified water (20) PEG / PPG / Polybutylene Glycol-8 / 5 / 3 Glycerin 3 (21) Methyl gluceth-10 3 (22) Carbomer 0.18 (23) Alcaligenes acid polysaccharide 0.01 (24) Sodium alginate 0.01 (25) Sodium hydroxide 0.05 (26) Purified water 1 (Note 2)

[0059] (Manufacturing method) A: Heat ingredients (1) to (4) to 70°C and mix uniformly. B: Heat component (5) to 70°C. C: Gradually add B to A and disperse using a Despa mixer. D: C was cooled to room temperature and liposomes were prepared. E: Heat ingredients (6) to (8) to 70°C and mix uniformly. F: Heat ingredients (9) to (18) to 70°C and mix uniformly. G: Heat ingredients (20) and (21) to 70°C and mix uniformly. H: Gradually add F to E and disperse using a Despa mixer. I: Gradually add G to H and emulsify using a Despa mixer. J: I was cooled to 40° C., and components (22) to (26) were gradually added and dispersed using a Despa mixer to prepare an emulsion. K: D was gradually added to J and mixed in a Despa mixer to obtain an eye cream containing both liposomes and emulsion.

[0060] (result) The obtained eye cream had excellent coexistence stability of the liposome and emulsion, and had a rich feel and a good penetration feel.

[0061] Example 23: Body Cream (Component) (%) (1) Phospholipids 1 (2) Phytosterol 0.2 (3) Glycerin 2 (4) DPG 2 (5) Purified water 20 (6) Phospholipids 1 (7) Glycerin 3 (8) 1,3-butylene glycol 10 (9) Sodium stearoyl glutamate 0.2 (10) Dimethicone (100CS) 1 (11) Liquid Paraffin 5 (12) Vaseline 1 (13) Cetyl ethylhexanoate 3 (14) Di(octyldodecyl / phytosteryl / behenyl) lauroyl glutamate 0.7 (15) Phytosteryl Oleate 0.3 (16) Cetostearyl alcohol 0.6 (17) Behenyl alcohol 0.8 (18) Remaining purified water (19) Glycerin 5 (20) PEG / PPG / Polybutylene Glycol-8 / 5 / 3 Glycerin 3 (21) Glycereth-26 3 (22) Acrylic acid / alkyl methacrylate copolymer 0.2 (23) Hydroxypropyl methylcellulose 0.05 (24) Sodium hydroxide 0.05 (25) Purified water 1

[0062] (Manufacturing method) A: Heat ingredients (1) to (4) to 70°C and mix uniformly. B: Heat component (5) to 70°C. C: Gradually add B to A and disperse using a Despa mixer. D: C was cooled to room temperature and liposomes were prepared. E: Heat ingredients (6) to (8) to 70°C and mix uniformly. F: Heat ingredients (9) to (17) to 70°C and mix uniformly. G: Heat ingredients (18) to (21) to 70°C and mix uniformly. H: Gradually add F to E and disperse using a Despa mixer. I: Gradually add G to H and emulsify using a Despa mixer. J: I was cooled to 40° C., and components (22) to (25) were gradually added and dispersed using a Despa mixer to prepare an emulsion. K: D was gradually added to J and mixed in a Despa mixer to obtain a body cream containing both liposomes and emulsion.

[0063] (result) The obtained body cream had excellent coexistence stability of the liposomes and emulsion, and had a rich feel and a good penetration feel.

Claims

1. The topical skin composition contains the following components (A) to (F), Component (A) Phospholipids Component (B) Phytosterol Component (C) Polyhydric alcohol having an IOB value of 1.8 to 3.5 and a polyhydric alcohol having an IOB value of 4.5 to 5.5 Polyhydric alcohol A liposome containing Component (D) Phospholipids Component (E) Oil Component (F) Higher alcohol and an emulsion comprising: Contains The component (E) oil agent contains at least dimethicone and a polar oil that is paste-like at 25°C, The paste-like polar oil has a melting point at a temperature higher than 25° C. and a viscosity at 30° C. of 5,000 to 100,000 mPa s, The paste-like polar oil is one or more selected from the group consisting of N-acylamino acid esters, glycerol fatty acid esters, dimer acid esters, dipentaerythritol fatty acid esters, fatty acid cholesteryl esters, and fatty acid phytosteryl esters; The content of the component (E) oily agent contained in the composition for external use on the skin is 10% by mass or more based on the entire composition for external use on the skin, and the content of the polar oil that is in a paste form at 25°C contained in the composition for external use on the skin is 1 to 5% by mass based on the entire composition for external use on the skin. The composition for external application to skin.

2. The composition for external use on the skin according to claim 1, wherein the mass ratio of the non-polar oil containing dimethicone to the polar oil containing a polar oil in a paste form at 25°C in the component (E) contained in the composition for external use on the skin: (mass of non-polar oil) / (mass of polar oil) is 0.8 to 2, and the paste-like polar oil is a polar oil having a melting point at a temperature above 25°C and a viscosity at 30°C of 5000 to 100000 mPa·s.

3. The composition for topical application to the skin according to claim 1 or 2, wherein the rate of change in the composition for topical application to the skin is less than 40%. Rate of change = average particle size derived from liposomes of a sample stored at 40°C for one month / average particle size derived from liposomes of a sample immediately after production

Citation Information

Patent Citations

  • Vesicle composition and external preparation for skin

    CN101686911B

  • Optical glass

    JP1982056344A

  • Manufacture of shock absorber

    JP1983025934A

  • Inverter device

    JP1988077381A

  • Skin preparation for external use

    JP1996183726A